EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-ND 4.0

Role of Aldosterone in Mid- and Long-Term Left Ventricular Remodelling after Acute Myocardial Infarction: The REMI Study

Luca Monzo iD, Olivier Huttin, João Pedro Ferreira, Zohra Lamiral, Erwan Bozec, Marine Beaumont, Emilien Micard, Guillaume Baudry, Pierre-Yves Marie, Romain Eschalier, Patrick Rossignol, Faiez Zannad und 1 weitere

European Journal of Heart Failure · 01.10.2023 · 25 (10) · 1742-1752

DOI: 10.1002/ejhf.2986 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift European Journal of Heart Failure, online erschienen am 24.08.2023. Verfasst von Luca Monzo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lorraine, Centre d'Investigations Cliniques Plurithématique 1433 and Inserm U1116, CHRU Nancy, FCRIN INI-CRCT (Cardiovascular and Renal…. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CHRU Nancy, Ministère de la Santé et des Services sociaux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Whether aldosterone levels after myocardial infarction (MI) are associated with mid- and long-term left ventricular (LV) remodelling in the era of systematic use of renin–angiotensin system inhibitors is uncertain. We prospectively investigated the relationship between aldosterone levels and mid- and long-term LV remodelling in patients with acute MI. Methods and results Plasma aldosterone was measured in 119 patients successfully treated by primary percutaneous coronary angioplasty for a first acute ST-elevation MI (STEMI) 2–4 days after the acute event. LV volumes were assessed by cardiac magnetic resonance (CMR) and transthoracic echocardiography (TTE) in the same timeframe and 6 months later. LV assessment was repeated by TTE 3–9 years after MI (n = 80). The median aldosterone level at baseline was 23.1 [16.8; 33.1] pg/ml. In the multivariable model, higher post-MI aldosterone concentration was significantly associated with more pronounced increase in LV end-diastolic volume index (TTE: β ± standard error [SE]: 0.113 ± 0.046, p = 0.015; CMR: β ± SE: 0.098 ± 0.040, p = 0.015) and LV end-systolic volume index (TTE: β ± SE: 0.083 ± 0.030, p = 0.008; CMR: β ± SE: 0.064 ± 0.032, p = 0.048) at 6-month follow-up, regardless of the method of assessment. This result was consistent also in patients with a LV ejection fraction (LVEF) >40%. The association between baseline plasma aldosterone and adverse LV remodelling did not persist at the 3–9-year follow-up evaluation.

Conclusion

Aldosterone concentration in the acute phase was associated with adverse LV remodelling in the medium term, even in the subgroup of patients with LVEF >40%, suggesting a potential role of the mineralocorticoid system in post-MI adverse remodelling. Plasma aldosterone was no longer associated with LV remodelling in the long term (NCT01109225).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocardial InfarctionST Elevation Myocardial InfarctionHumansAldosteroneStroke VolumeVentricular Function, LeftVentricular Remodeling

Stichwörter der Autor:innen

AldosteroneCardiovascular diseaseLeft ventricular remodellingLong-term follow-upMyocardial infarction

Substanzen

Aldosterone

Autor:innen und Institutionen

  • Université de Lorraine, Centre d'Investigations Cliniques Plurithématique 1433 and Inserm U1116, CHRU Nancy, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
  • Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Centre d'Investigations Cliniques IADI U947, Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France.
  • CHRU-Nancy, Université de Lorraine, Nuclear Medicine & Nancyclotep Imaging Platform, Nancy, France.
  • Cardiology Department, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, Clermont-Ferrand, France.

ORCID-Profile: Luca Monzo

Förderung

  • CHRU Nancy
  • Ministère de la Santé et des Services sociaux

Zitieren

APA

Monzo, L., Huttin, O., Ferreira, J. P., Lamiral, Z., Bozec, E., Beaumont, M., Micard, E., Baudry, G., Marie, P. Y., Eschalier, R., Rossignol, P., Zannad, F., & Girerd, N. (2023). Role of Aldosterone in Mid- and Long-Term Left Ventricular Remodelling after Acute Myocardial Infarction: The REMI Study. European Journal of Heart Failure, 25(10), 1742-1752. https://doi.org/10.1002/ejhf.2986

Vancouver

Monzo L, Huttin O, Ferreira JP, Lamiral Z, Bozec E, Beaumont M, et al. Role of Aldosterone in Mid- and Long-Term Left Ventricular Remodelling after Acute Myocardial Infarction: The REMI Study. European Journal of Heart Failure. 2023;25(10):1742-1752. doi:10.1002/ejhf.2986

BibTeX
@article{Monzo2023,
  author = {Monzo, Luca and Huttin, Olivier and Ferreira, João Pedro and Lamiral, Zohra and Bozec, Erwan and Beaumont, Marine and Micard, Emilien and Baudry, Guillaume and Marie, Pierre-Yves and Eschalier, Romain and Rossignol, Patrick and Zannad, Faiez and Girerd, Nicolas},
  title = {Role of Aldosterone in Mid- and Long-Term Left Ventricular Remodelling after Acute Myocardial Infarction: The REMI Study},
  journal = {European Journal of Heart Failure},
  year = {2023},
  volume = {25},
  number = {10},
  pages = {1742--1752},
  doi = {10.1002/ejhf.2986}
}
Kostenlos starten →